106 Cabazitaxel adverse events are manageable in senior adults with metastatic castration-resistant prostate cancer (mCRPC): Results of the European Compassionate Use Programme

✍ Scribed by Heidenreich, A.; Bracarda, S.; Mason, M.; Ozen, H.; Sengelov, L.; Gerritsen, W.; Papandreou, C.; Fossa, S.; Hitier, S.; Climent, M.

• Book ID: 123171524
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 102 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)60598-9